Phagocytic killing and antibody response during the first year after tetravalent meningococcal vaccine in complement-deficient and in normal individuals

Journal of Clinical Immunology

Volumn 20, Issue 1, 2000, Pages 46-53

  Schlesinger, Menache ^a   Kayhty, Helena ^b   Levy, Rachel ^c   Bibi, Chaim ^a   Meydan, Naftaly ^c   Levy, Jacov ^c  

^a BARZILAI MEDICAL CENTER   (Israel)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Complement deficiency; Meningococcus; Vaccination

Indexed keywords

MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; HUMAN; IMMUNITY; IMMUNOASSAY; PHAGOCYTOSIS; PRIORITY JOURNAL; VACCINATION;

ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; BLOOD BACTERICIDAL ACTIVITY; COMPLEMENT SYSTEM PROTEINS; HUMANS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; PHAGOCYTOSIS; POLYSACCHARIDES, BACTERIAL; TIME FACTORS; VACCINATION;

EID: 0034038050     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006642611069     Document Type: Article

References (20)

1. 1. Roberts RB: The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man. J Exp Med 131:409-513, 1970
2. 2. Ross SC, Rosentha PY, Densen P: Killing of Neisseria meningitidis by human neutrophils: Implications for normal and complement deficient individuals. J Infect Dis 126:1266-1275, 1987
3. 3. Biselli R, Casapollo I, D'Amelio R, Salvato S, Marticardi PM, Brai M: Antibody response to meningococcal polysaccharide A and C in patients with complement defects. Scand J Immunol 37:644-650, 1993
4. 4. Schlesinger M, Greenberg M, Levy J, Kayhty H, Levy R: Killing of meningococci by neutrophils-Effect of vaccination in patients with complement deficiency. J Inf Dis 170:449-453, 1994
5. 5. Andreoni J, Kayhty H, Densen P: Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals. J Inf Dis 168:227-231, 1993
6. 6. Platonov AE, Beloborodov VB, Pavlova LI, Vershinina IV, Kayhty H: Vaccination of patients deficient in a late complement component with tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 100:32-39, 1995
7. 7. Levy R, Klein J, Rubinek T, Alkan M, Shany S, Chaimovitz C: Diversity in peritoneal macrophages of CAPD patients to 1.25 dihydroxyvitamin D3. Kidney Int 37:310-315, 1990
8. 8. Ross SC, Densen P: Opsonophagocytosis of Neisseria gonorrhea interaction of local and disseminated isolates with complement and neutrophils. J Infect Dis 15:33-41, 1985
9. 9. Arakere G, Frasch CE: Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccines and carriers. Inf Imm 59:4349-4356, 1991
10. 10. Holder PK, Maslanka SE, Pais LB, Dykes J, Plikaytis BD, Carlone GM: Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentration to the new standard reference serum CDC1992. Clin Diag Lab Immunol 2:132-137, 1995
11. 11. Ross SC, Densen P: Congenital deficiency states and infections. Epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine 63:243-273, 1984
12. 12. Densen P: Complement deficiencies and meningococcal disease. Clin Exp Immunol 86:(Suppl 1) 57-62, 1991
13. 13. Wurzner R, Oren A, Lacman PJ: Inherited deficiencies of the terminal components of human complement. Immunodeficiency Reviews 3:123-147, 1992
14. 14. Potter PC, Fresch CE, van-der-Sande WJ, Cooper RC, Patel Y, Orren A: Prophylaxis against Neisseria meningitidis infections and antibody response in patients with deficiency of the sixth component of complement. J Infect Dis 161:932-937, 1990
15. 15. Densen P, Brown EJ, O'Neill GJ, Tedesco F, Clark RA, Frank MM, Webb D, Myers J: Inherited deficiency of C8 in a patient with recurrent meningococcal infections: further evidence for a dysfunctional C8 molecule and non-linkage to the HLA system. J Clin Immunol 3:90-99, 1983
16. 16. Meningitis and Special Pathogens Branch, Division of Bacterial Diseases, Center for Infectioious Disease, CDC: Availability of meningococcal vaccine in single-dose for travellers and high risk persons. MMWR 39:763, 1990
17. 17. Platonov AE, Vershinia IV, Dankert J, Kuijper EJ, Gustafson L, Kayhty H: Long-term follow-up of late complement component deficient patients vaccinated with meningococcal polysaccharide vaccine: Antibody persistence and efficacy of vaccination (Abst.). Tenth International Pathogenic Neisseria Conference, Baltimore, Maryland, USA, September 1996
18. 18. Fijen CAP, Kuijper EJ, Drogari-Apiranthitou M, Van Leeuwen Y, Daha MR, Dankert J: Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysacharide vaccine. Clin Exp Immunol 114:362-369, 1998
19. 19. Orren A, Warren RE, Potter PC, Jones AM, Lachmann PJ, Poolman JT: Antibodies to meningococcal class I outer membrane proteins in south Africa complement-deficient and complement-sufficient subjects. Infect Immun 60:4510-4516, 1992
20. 20. King WJ, MacDonald NE, Wells G, Allen U, Chan F, Ferris W, Diaz-Mitoma F, Ashton F: Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children. J Pediatr 128:196-202, 1996